Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | RECQL | P46063 | 1/20 | 0.30 |
| ▸ | CASP2 | P42575 | 1/20 | 0.30 |
| ▸ | EPOR | P19235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21172401 | 0.90 | GLP1R (0.47) | GLP1RMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL21172359 | 0.89 | GLP1R (0.49) | GLP1RMEN1KMT2AALDH1A1RECQL | |
| SCHEMBL22627089 | 0.77 | GLP1R (0.56) | GLP1R | |
| SCHEMBL12518540 | 0.77 | GLP1R (0.60) | GLP1R | |
| SCHEMBL12424086 | 0.76 | GLP1R (0.62) | GLP1R | |
| SCHEMBL19786696 | 0.74 | GLP1R (0.59) | GLP1RMEN1KMT2A | |
| SCHEMBL24198474 | 0.73 | GLP1R (0.48) | GLP1RMEN1KMT2ARECQL | |
| SCHEMBL71906 | 0.73 | MEN1 (0.45) | GLP1RMEN1KMT2ARECQL | |
| SCHEMBL14683533 | 0.73 | GLP1R (0.48) | GLP1RMEN1KMT2ARECQL | |
| SCHEMBL17401159 | 0.73 | GLP1R (0.64) | GLP1R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2525834-B1 | GROWTH HORMONES WITH PROLONGED IN-VIVO EFFICACY | NOVO NORDISK HEALTHCARE AG (CH) | 2019-07-17 | — | — | EP | disclosed |